Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 362,578 | 239,087 | 216,454 | 154,247 | 173,197 |
| Marketable Securities | 50,311 | 50,354 | 0 | 24,605 | 3,964 |
| Receivables | 44,660 | 46,525 | 40,378 | 44,021 | 41,461 |
| Inventories | 20,546 | 21,750 | 16,128 | 14,294 | 11,225 |
| TOTAL | $488,376 | $372,267 | $285,621 | $248,636 | $243,102 |
| Non-Current Assets | |||||
| PPE Net | 22,192 | 22,953 | 20,584 | 17,702 | 15,098 |
| Intangibles | 856,302 | 848,101 | 791,577 | 870,757 | 910,635 |
| Other Non-Current Assets | 39,149 | 56,714 | 17,124 | 19,327 | 18,990 |
| TOTAL | $917,643 | $927,768 | $829,285 | $907,786 | $944,723 |
| Total Assets | $1,406,019 | $1,300,035 | $1,114,906 | $1,156,422 | $1,187,825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,127 |
| Accounts payable and accrued liabilities | 4,593 | 8,634 | 12,943 | 11,911 | 12,360 |
| Accrued Expenses | 48,801 | 43,826 | 38,427 | 37,774 | 39,475 |
| Other current liabilities | 1,332 | 17,000 | 2,758 | 6,246 | 2,913 |
| TOTAL | $59,937 | $78,633 | $61,241 | $62,614 | $64,151 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,160 | 1,673 | 2,008 | 2,613 | 4,646 |
| Other Non-Current Liabilities | 35,860 | 44,209 | 8,829 | 14,077 | 21,225 |
| TOTAL | $36,506 | $45,436 | $9,563 | $18,608 | $27,160 |
| Total Liabilities | $96,443 | $124,069 | $70,804 | $81,222 | $91,311 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,458 | 77,945 | 75,068 | 72,150 | 71,218 |
| Common Shares | 79 | 78 | 73 | 72 | 71 |
| Retained earnings | -377,630 | -443,983 | -468,121 | -393,717 | -357,157 |
| Other shareholders' equity | -8,212 | -36,090 | -24,018 | -31,346 | -15,083 |
| TOTAL | $1,309,576 | $1,175,966 | $1,044,102 | $1,075,200 | $1,096,514 |
| Total Liabilities And Equity | $1,406,019 | $1,300,035 | $1,114,906 | $1,156,422 | $1,187,825 |